TOPICAINE
- Product NDC
- 63135-312
- Requested package NDC
- 63135-312-30
- 11-digit product format
- 631350312
- Labeler code
- 63135
- Product ID
- 63135-312_47e8cec4-fde0-1956-e063-6394a90a1bdc
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- LIDOCAINE 4%
- Dosage form
- GEL
- Route
- TOPICAL
- Labeler
- ESBA LABORATORIES INC.
- Application
- M017
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2003-04-20
- Substance
- LIDOCAINE
- Active strength
- 4 g/100g
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 63135-312 | 63135-312-30 | D | Discontinued by firm | 2026-11-19 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | D | Discontinued by firm | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | D | Discontinued by firm | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | D | Discontinued by firm | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | D | Discontinued by firm | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | D | Discontinued by firm | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | D | Discontinued by firm | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | D | Discontinued by firm | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | D | Discontinued by firm | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | D | Discontinued by firm | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | D | Discontinued by firm | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | D | Discontinued by firm | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | I | Inactivated by FDA | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | I | Inactivated by FDA | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | I | Inactivated by FDA | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | I | Inactivated by FDA | 1332a3947898… | d4bfe170f9cd… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TOPICAINE
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LIDOCAINE | 4 g/100g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 98PI200987 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7f96e980-891e-743d-e053-2a91aa0aea5f | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 070fbed5-7088-434a-a7ce-f2a64d8d40ac | Product name | 2 | 20260107 |
| bee66ce1-adb7-9d3b-67d9-582e4c54e80f | Product name | 5 | 20250819 |
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 777d68c6-a5ab-e06c-d314-677b0b9af0c8 | Product name | 2 | 20240508 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| 7d755fa1-1087-4dcd-98f0-6d4bba479a57 | Product name | 3 | 20210602 |
| aed701d5-9c75-dfaf-7154-cde46179faea | Product name | 9 | 20200313 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
| 49fa150c-f0de-cce7-3d9c-993ed81c5698 | Product name | 1 | 20140508 |
| 4d7ae718-ed00-bae8-2abe-9eaec1eef7ff | Product name | 1 | 20140508 |
| 9137811f-f279-8640-5aeb-99fa2145d64d | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 63135-312-04 | 2024-09-21 | TOPICAINE |
| 63135-312-04 | 2024-09-21 | TOPICAINE |
| 63135-312-13 | 2024-09-21 | TOPICAINE |
| 63135-312-13 | 2024-09-21 | TOPICAINE |
| 63135-312-30 | 2024-09-21 | TOPICAINE |
| 63135-312-30 | 2024-09-21 | TOPICAINE |
| 63135-312-04 | 2023-01-30 | TOPICAINE |
| 63135-312-04 | 2023-01-30 | TOPICAINE |
| 63135-312-13 | 2023-01-30 | TOPICAINE |
| 63135-312-13 | 2023-01-30 | TOPICAINE |
| 63135-312-30 | 2023-01-30 | TOPICAINE |
| 63135-312-30 | 2023-01-30 | TOPICAINE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63135-312-04 | TOPICAINE | 113 g in 1 TUBE | GEL | 113 | 5 | |
| 63135-312-13 | TOPICAINE | 10 g in 1 TUBE | GEL | 10 | 5 | |
| 63135-312-13 | TOPICAINE | 1 in 1 BOX | GEL | 1 | 5 | |
| 63135-312-30 | TOPICAINE | 1 in 1 BOX | GEL | 1 | 5 | |
| 63135-312-30 | TOPICAINE | 30 g in 1 TUBE | GEL | 30 | 5 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63135-312-04 | GM - Gram | 63135-312 | 477107f9-14e6-49b4-9bc3-5ba2f4b06dfc | 1 | 2015-06-09 |
| 63135-312-13 | GM - Gram | 63135-312 | 4683b683-a1f1-476f-ba81-ec4e7d0df609 | 1 | 2015-06-09 |
| 63135-312-30 | GM - Gram | 63135-312 | 7cd93361-2de8-46e6-8d3e-cefdcf7482c7 | 1 | 2015-06-09 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CVS Cold and Hot | MENTHOL | CVS Pharmacy | a44cec95-822a-40b6-e053-2995a90ae31c | 2026-10-29 | Warnings | M017 |
| Kyvirro Numbing Cream | MENTHOL 8% | Guangzhou Huixue Biotechnology Co., Ltd. | 5f059a82-35b0-cd1d-e063-6294a90aa9f5 | 2026-10-29 | Warnings | M017 |
| 5Kind DMSO Roll-On Pain Relieving | MENTHOL, METHYL SALICYLATE | 5Kind Trading LTD | 3d881288-4c2a-4140-b6fe-5ba619124b9e | 2026-10-28 | Warnings | M017 |
| Amino Activ Pain Relief | HISTAMINE DIHYDROCHLORIDE | Vireo Systems, Inc | bfd89e8a-cd22-495a-8741-c19aceb92b2b | 2026-10-28 | Warnings | M017 |
| Stopain Clinical | MENTHOL, UNSPECIFIED FORM | Troy Manufacturing, Inc. | 4503208f-2808-4727-8066-c431230bd70b | 2026-10-28 | Warnings | M017 |
| Dr Sabharwals | LIDOCAINE 4% GEL PATCH | Dr. Sabharwal's Wound Care | 102399b6-5be9-ee5e-e063-6394a90a3198 | 2026-10-28 | Warnings | M017 |
| Dr Sabharwals | MENTHOL 5% PATCH | Dr. Sabharwal's Wound Care | 1025b986-a1e5-701d-e063-6294a90a33fd | 2026-10-28 | Warnings | M017 |
| Coralite Pain Relief Hot | MENTHOL AND CAPSAICIN | United Exchange Corporation | 78eb133d-01bb-6466-e053-2991aa0accc0 | 2026-10-28 | Warnings | M017 |
| Coralite Odor Free Pain Relief | LIDOCAINE | United Exchange Corporation | 7966d9f2-22f9-a900-e053-2991aa0aba55 | 2026-10-28 | Warnings | M017 |
| PERFORM LEO EXTENSIVE PAIN RELIEF | LIDOCAINE, MENTHOL | PERFORM LEO LLC | f993ed5f-7dbb-4e3e-addf-f65b12f5cc48 | 2026-10-28 | Warnings | M017 |
| Coralite Ultra Strength Pain Relief | CAMPHOR MENTHOL | United Exchange Corp. | 44ecf959-cc07-4adc-a500-075b2ee69548 | 2026-10-28 | Warnings | M017 |
| Mineral Ice Pain Relieving | MENTHOL | Crown Laboratories | 7b30076a-0af6-2f74-e053-2a91aa0ae08d | 2026-10-28 | Warnings | M017 |
| Foot and Leg Pain Relief | LIDOCAINE | Premier Brands of America Inc. | 42f23e2f-11c6-da49-e063-6294a90ac720 | 2026-10-28 | Warnings | M017 |
| Coralite Pain Relief | CAMPHOR, MENTHOL, METHYL SALICYLATE | United Exchange Corp. | 69aec845-3d4c-d226-e053-2991aa0afd12 | 2026-10-28 | Warnings | M017 |
| Lidocaine 4% Patch | LIDOCAINE 4% | V2 Pharma, LLC | 9c8e4039-74a0-4747-90b8-456a295cd2c8 | 2026-10-28 | Warnings | M017 |
| QUALITY CHOICE Maximum Strength Lidocaine Pain Relief Roll On | LIDOCAINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION | 7b3ff4c1-0b60-4f7a-8aa4-c84b7c7137c4 | 2026-10-28 | Warnings | M017 |
| Band Aid Antiseptic Cleansing | BENZALKONIUM CHLORIDE, PRAMOXINE HCL | Kenvue Brands LLC | d55e6b09-0587-61a9-e053-2995a90afaf5 | 2026-10-27 | Warnings | M017 |
| Blue Ice Analgesic | MENTHOL | Delon Laboratories (1990) Ltd | 184ed488-6e62-40c6-bb71-1d523280fd6b | 2026-10-27 | Warnings | M017 |
| La Vaquita New Extra | METHYL SALICYLATE, MENTHOL | Delon Laboratories (1990) Ltd | 3097a01b-cee5-492f-b65a-63992fb28e3a | 2026-10-27 | Warnings | M017 |
| La Vaquita New Regular | METHYL SALICYLATE | Delon Laboratories (1990) Ltd | d62186ac-afbb-443e-98c2-f0d122422a3c | 2026-10-27 | Warnings | M017 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1291672 | lidocaine 4 % Topical Gel | PSN | 7f96e980-891e-743d-e053-2a91aa0aea5f | 5 |
| 1651001 | Topicaine 4 % Topical Gel | PSN | 7f96e980-891e-743d-e053-2a91aa0aea5f | 5 |
| 1651001 | lidocaine 0.04 MG/MG Topical Gel [Topicaine] | SBD | 7f96e980-891e-743d-e053-2a91aa0aea5f | 5 |
| 1291672 | lidocaine 0.04 MG/MG Topical Gel | SCD | 7f96e980-891e-743d-e053-2a91aa0aea5f | 5 |
| 1291672 | lidocaine 4 % Topical Gel | SY | 7f96e980-891e-743d-e053-2a91aa0aea5f | 5 |
| 1651001 | Topicaine 4 % Topical Gel | SY | 7f96e980-891e-743d-e053-2a91aa0aea5f | 5 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 63135-312-30 | 63135031230 | 1 TUBE in 1 BOX (63135-312-30) / 30 g in 1 TUBE | 1 tube | 2003-04-20 | 0000-00-00 | No | No | Current |